Back to
VANGUARD GROUP INC
INO6 quarters
Position history for
VANGUARD GROUP INC's holdings in INOVIO PHARMACEUTICALS INC
As of its last 13F, for Q4 2025, Vanguard Group held 3,315,580 shares of INO (Inovio Pharmaceuticals), worth $5.8M. It increased the position by 602,708 shares (+22.2%) from Q3 2025. Vanguard Group held INO from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$5.8M
Current Shares
3.3M
Total Value Change
-$4.6M
Total Shares Change
+1.5M
Quarter-by-Quarter History
Other major holders of INO: FMR LLC, BlackRock Finance, Inc., BlackRock, Inc.